TOVALT Trademark

Trademark Overview


On Tuesday, September 15, 2020, a trademark application was filed for TOVALT with the United States Patent and Trademark Office. The USPTO has given the TOVALT trademark a serial number of 90182924. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 3, 2024. This trademark is owned by Melbourne Laboratories LLC. The TOVALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's dise...
tovalt

General Information


Serial Number90182924
Word MarkTOVALT
Filing DateTuesday, September 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the prevention and treatment of disorders, diseases, conditions and ailments of the immune system, cardio-vascular system, respiratory system, musculoskeletal system and central nervous system; pharmaceutical preparations and substances for the prevention and treatment of inflammatory disorders; pharmaceutical preparations and substances for the prevention and treatment of hypertension; pharmaceutical preparations and substances for the prevention and treatment of oncologic and metabolic disorders, diseases, conditions and ailments; pharmaceutical preparations and substances for use in dermatology; pharmaceutical preparations and substances for the treatment of depression, obsessive compulsive disorders, central nervous system movement disorders, spinal cord diseases, encephalitis, epilepsy, cerebral palsy, Parkinson's disease, insomnia, mood disorders, bipolar disorder, seizure disorders, brain injury, spinal cord injury, Alzheimer's disease, Huntington's disease and cerebral palsy; pharmaceutical preparations and substances for the prevention, treatment and alleviation of psychiatric disorders, diseases, conditions and ailments, namely, mood disorders, anxiety disorders, panic disorders, bipolar disorder, cognitive disorders, schizophrenia and depression; pain relief medications and analgesics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMelbourne Laboratories LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040

Party NameMelbourne Laboratories LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040

Trademark Events


Event DateEvent Description
Friday, September 18, 2020NEW APPLICATION ENTERED
Wednesday, January 27, 2021ASSIGNED TO EXAMINER
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, October 1, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 1, 2021SOU EXTENSION 1 FILED
Friday, October 1, 2021SOU EXTENSION 1 GRANTED
Friday, April 1, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 1, 2022SOU EXTENSION 2 FILED
Friday, April 1, 2022SOU EXTENSION 2 GRANTED
Tuesday, April 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU EXTENSION 3 FILED
Wednesday, September 28, 2022SOU EXTENSION 3 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023SOU EXTENSION 4 FILED
Wednesday, March 29, 2023SOU EXTENSION 4 GRANTED
Friday, March 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 25, 2023SOU EXTENSION 5 FILED
Tuesday, October 3, 2023SOU EXTENSION 5 GRANTED
Tuesday, October 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED